November 29, 2018
Genetics Signatures (ASX:GSS) Chairman’s Address to Shareholders
November 26, 2018
Genetics Signatures (ASX:GSS) 2018 Investor Presentation for AGM Meeting
October 29, 2018
Genetics Signatures (ASX:GSS) 2018 Annual Report to Shareholders
October 29, 2018
Genetics Signatures (ASX:GSS) – Notice of Annual General Meeting & Proxy Form
October 29, 2018
Genetics Signatures (ASX:GSS) – Appendix 4C Quarterly Report September 2018
September 17, 2018
Date of 2018 Annual General Meeting of Shareholders (GSS: ASX)
Genetic Signatures Limited (ASX: GSS) has announced its date of 2018 Annual General Meeting. For more information click the link
Date of Annual General Meeting 2018
September 10, 2018
Genetic Signatures’ CEO Dr. John Melki interview by Proactive Investors
Genetic Signatures’ CEO Dr. John Melki was recently interviewed by Proactive investors at the ASX Small and Mid-Cap Conference.
See the link below to learn more about our 3baseTM technology and EasyScreenTM assays, and how we’re improving patient outcomes.
For more information click the link: Genetic Signatures’ clinical trials demonstrate product efficacy.
